Professor Dr. Cornelis (Kees) Kluft

Prof. Dr. Kluft is the founder and CEO of GBS Leiden, and a renowned expert in haemostasis and human biomarkers. He was projectleader of projects of several large pharmaceutical companies, as well as different academic research organizations and charitable foundations supporting patient groups. He started his career in haemostasis (fibrinolysis) at TNO (Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek) in 1972. Continuing as TNO’s Haemostasis specialist and division head of vascular medicine and connective tissue research and was one of the founders of TNO Pharma. He is chairman of the supervisory board of ECAT, external quality assessment organisation. He previously held positions as Professor in Thrombosis Research (University of Southern Denmark) and in Cardiovascular Biology (Catholic University, Italy).
After 33 years he left TNO, started GBS and continued working with the CHDR (Centre for Human Drug Research) as a biomarker specialist. Presently, he is also visiting professor at the University of Southern Denmark in Esbjerg University, in a joint programme on biocompatibility and contact activation.

Tel:      +31 (0)6 53 62 22 21

Dr. Dimitar Tasev, MD

Dimitar Tasev  is the Scientific officer at GBS specialized in functional cellular assays in the field of immunity, inflammation, neurodegeneration, stem cell and vascular cell biology.
He was educated and worked as an MD in Macedonia until 2009 when he moved to the Netherlands to pursue an MSc degree in Biomedical Sciences. During the two one-year research specializations in Advanced Immunology and Cardiovascular Research, he investigated the immunological aspects of multiple sclerosis and the role of endothelial progenitor cells in angiogenesis. Prior to his current position, he investigated the biological response of endothelial progenitor cells to hypoxia and inflammation in 3D matrices during angiogenesis as a PhD student at ICaR-VU, VUmc, Amsterdam. In the course of his stay in academia, he obtained broad knowledge of molecular biology techniques, cell culture, tissue engineering and assay development.

Tel:      +31 (0)71 751 71 74

Dr. Barbara Franke

Barbara Franke is the Senior Scientist and Laboratory Coordinator at GBS .
She trained as a molecular and structural biologist at the University of Liverpool in the UK, obtaining her PhD in 2013. Her scientific background in the past focused on using structural information to guide research into protein function and protein interactions important in muscle homeostasis and muscle disease. Previous to her role at GBS she worked as a Postdoctoral Researcher and Laboratory Manager coordinating the day-to-day work of her previous laboratory. During her research, she obtained broad experience in molecular biology and biochemical techniques, as well as project management. She brings expertise in protein engineering and characterization.

Tel:      +31 (0)71 751 71 70

Bastiaan Kluft, MSc

Bastiaan is Managing Director, responsible for daily management and business development at GBS. He obtained his Master’s degree in Chemistry in 2014 from Leiden University, specializing in (bio-)organic chemistry and science based business. During his education he familiarized himself with the work at GBS through several temporary jobs. Following his studies he pursued a management traineeship at KPN shortly followed by founding his own company SeraNovo in innovative pharmaceutical formulations. During this period he acquired a working knowledge of how to find value in science and turn it into business within the pharmaceutical industry, as well as managerial skills and experience in the world of investments and start-ups.

Tel: +31 (0)71 751 71 70